Methods and compositions for generating human monoclonal antibodies

Details for Australian Patent Application No. 2001231172 (hide)

Owner Raven biotechnologies, inc.

Inventors Li, Ronghao

Agent FB Rice

Pub. Number AU-B-2001231172

PCT Pub. Number WO01/55216

Priority 09491894 26.01.00 US

Filing date 26 January 2001

Wipo publication date 7 August 2001

Acceptance publication date 25 May 2006

International Classifications

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

Event Publications

11 May 2006 Amendment Made

  The nature of the amendment is: Amend the name of the applicant from Raven Biotechnologies, Inc to Raven biotechnologies, inc.

25 May 2006 Application Accepted

  Published as AU-B-2001231172

21 September 2006 Standard Patent Sealed

9 December 2010 Alteration of Name

  The name of the patentee has been altered to MacroGenics West, Inc. 2002

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001231173

2001231171-Synthetic internal ribosome entry sites and methods of identifying same